Anthony Gulati, MD

Hematology Oncology PC

One Hospital Plaza
Stamford, CT 06902

Main: (203) 276-2695
Fax: (203) 975-7842

About Me

Dr. Anthony Gulati witnessed the evolution of oncology by watching his father practice medicine. After seeing the advances in the field and the great relationships his father developed with his patients, Dr. Gulati chose to practice oncology as well.

Dr. Gulati believes in a personal touch with his patients, striving to develop open communication and always remain accessible. He enjoys working with his patients to solve difficult treatment problems and offers personalized care to fit his patients’ needs.

After receiving his specialized fellowship training at Columbia University, Dr. Gulati chose to focus on treating patients with genitourinary, gastrointestinal, and neuroendocrine cancers. In 2015, Dr. Gulati was awarded the Rookie of the Year award in the Department of Medicine at Stamford Health for quality patient care during his first year of service. Dr. Gulati helps shape the future of oncology through clinical research and by serving as a clinical professor of medicine at Columbia University. He uses the latest treatments, including immunotherapy and clinical trials, to help his patients fight cancer.

icon globe



icon operation


Medical Oncology

icon doctor

special interests

  • Genital urinary cancers
  • Prostate cancer
  • Testicular cancer
  • Kidney cancer
  • Bladder cancer
  • Gastrointestinal cancers
  • Neuroendocrine cancers
  • Hematologic disorders and malignancies
  • Lung Cancer


icon education

Education & Training

Medical School

Perelman School of Medicine at the University of Pennsylvania


University of Pennsylvania Health System


New York Presbyterian Hospital

icon award


Published Work

Zacharia BE, Gulati AP, Bruce JN, Carminucci AS, Wardlaw SL, Siegelin M, Remotti H, Lignelli A, Fine RL. High response rates and prolonged survival in patients with corticotroph pituitary tumors and refractory Cushing disease from capecitabine and temozolomide (CAPTEM): a case series. Neurosurgery. 2014 Apr;74(4):E447-55; discussion E455. doi: 10.1227/NEU.0000000000000251.


Fine RL, Gulati AP, Krantz BA, Moss RA, Schreibman S, Tsushima DA, Mowatt KB, Dinnen RD, Mao Y, Stevens PD, Schrope B, Allendorf J, Lee JA, Sherman WH, Chabot JA. Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience. Cancer Chemother. Pharmacol. 2013 Mar;71(3):663-70. doi: 10.1007/s00280-012-2055-z. Epub 2013 Jan 31.


Gulati AP, Krantz B, Moss RA, Moyal WN, Tsushima DA, Mowatt KB, Schreibman S, Fine RL. Treatment of multiple endocrine neoplasia 1/2 tumors: case report and review of the literature. Oncology. 2013;84(3):127-34. doi: 10.1159/000342961. Epub 2012 Dec 8.


Gulati AP, Saif MW. Is there a role for liver transplantation in metastatic pancreatic neuroendocrine tumors (PNET)? JOP. 2012 May 10;13(3):320-1.


Gulati AP, Saif MW. Retinal neovascularization and hemorrhage associated with the use of imatinib (Gleevec(®)) in a patient being treated for gastrointestinal stromal tumor (GIST). Anticancer Res. 2012 Apr;32(4):1375-7.


Gulati AP, Domchek SM. The clinical management of BRCA1 and BRCA2 mutation carriers. Curr. Oncol. Rep. 2008 Jan;10(1):47-53.


Gulati AP, Yang YM, Harter D, Mukhopadhyay A, Aggarwal BB, Benzil DL, Whysner J, Albino AP, Murali R, Jhanwar-Uniyal M.

Mol Carcinog. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.

2006 Jan;45(1):26-37. Erratum in: Mol Carcinog. 2006. Jul;45(7):549.

Board Certifications

American Board of Internal Medicine


American Society of Clinical Oncology

If You Are in Need of Emergency Care, Call 911.

The majority of the physicians on the Stamford Hospital Medical Staff are not employees or agents of the Hospital. They are independent practitioners who have been granted the privilege of using the Hospital's facilities for the care and treatment of their patients. This includes, but is not limited to, emergency department physicians, anesthesiologists, radiologists, surgeons, cardiologists, obstetricians, pathologists and other consultants who may treat patients.

Insurance listings are subject to change at any time. Please verify insurance plan acceptance when scheduling an appointment with a healthcare provider.

Our website uses cookies

This website uses cookies to give you the very best experience. Your continued use of this site is considered permission by you to use cookies in this manner. Please review our Privacy Policy and Terms of Use for more information about the data we collect and the types of cookies we use. Please note, if you link off our website to a 3rd party site of any kind, that website has its own terms and conditions.